The antiviral drug remdesivir is supposed to stop SARS-CoV-2 from replicating, but a recent study published in the Lancet suggests it may not be working the way it is supposed to.
Category: healthcare
New Test Shows That IHME COVID-19 Death Projections Display Optimism Bias
The White House relies on unrealistically optimistic projections of number of U.S. deaths from COVID-19. In this post, I discuss evidence from a new test that supports this assertion.
Stocks Fall, Dow Loses 400 Points After Trump Threatens New Tariffs On China
The market is down over 2% after wrapping up its best month in decades.
Swearing: The Fastest Acting Pain Reliever Of Them All.
Scientists have just proven the unique power of swearing by inventing fake obscenities and comparing them to the classics.
Use Of Value-Based Contracting For Pharmaceuticals Is Underwhelming
Ultimately, better alignment of price and value of health technologies and medical services is the main objective of any healthcare system. This can be achieved through multiple means, including value-based contracts and coverage with evidence developm…
Coronavirus Crisis Exposes A Dangerous Law Putting Patients At Risk
The coronavirus catastrophe has put the spotlight on a law that harms our health.
Should Essential Workers Get Debt Forgiveness?
As essential workers are on the frontlines of the coronavirus, many are calling for student debt forgiveness to provide relief to them given their unique risks of exposure.
U.K. Lockdown Has ‘Broken HIV Chain’ With Huge Reduction In New STI Cases
The U.K. is seeing a huge reduction in new STI cases with the HIV Chain “broken,” in what sexual health advocates are calling a once in a lifetime opportunity.
Coronavirus Is Seriously Impacting FGM & Gender-Based Violence
People’s experiences of home are far from universal, and research has found that the COVID-19 lockdown could be seriously detrimental to ending gender-based violence, female genital mutilation and child marriages.
COVID-19 Prompts Regulation Rollbacks, And 3 May Have Lasting Effects For Health Care
At the beginning of 2017, the Trump Administration committed to reducing federal regulation and reining in regulatory costs. However, the SARS-CoV-2 coronavirus has infiltrated the legislative and regulatory world – just as it has every other facet of …
